Monday, April 13, 2026
wellness India Expo
Home Tags Serum Institute

Tag: Serum Institute

Biocon Biologics & Serum Institute Life Sciences announce strategic alliance

BBL will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets. SILS to receive ~15% stake in BBL at a post-money valuation of ~$4.9 billion......................

SCHOTT & Serum Institute announce JV for pharmaceutical packaging

Serum Institute of India (SII) acquires 50% stake of SCHOTT Kaisha to become SCHOTT’s joint venture partner and secure pharma packaging supply..........................

Serum Institute to produce 300 million doses of Sputnik V annually...

Technology transfer process has already started; cultivation process has begun following the approval by the Drug Controller General of India (DCGI).........................

Scale up the production capacity: PM Modi tells vaccine manufacturers

The prime minister, Narendra Modi interacted with vaccine manufacturers from across the country on April 20, 2021........................

Govt fast tracks emergency approvals for foreign produced COVID-19 vaccines

A lot many vaccines are expected to be granted Emergency Use Authorization in other countries for expanding the basket of vaccines for domestic use and hasten the pace and coverage of vaccination....................

Wait over as DCGI approves Bharat Biotech & Serum Institute COVID-19...

After adequate examination, Central Drugs Standard Control Organisation decided to accept the recommendations of the Expert Committee, and accordingly, vaccines of Serum and Bharat Biotech are being approved for restricted use in an emergency situation

Stakeholder orchestration a key for effective vaccination program: experts at NASSCOM

The funding for such large-scale distribution would be huge, and India should be ready with a funding of around Rs 80,000 crore for the next one year for distribution of the COVID-19 vaccine......................

India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan

Dr Harsh Vardhan at the India-Portugal Technology Summit2020 “The next iteration of this collaboration will be to encourage new solutions based on cutting edge technologies such as Machine Learning and Artificial Intelligence”...................

PM Modi visits India’s top private vaccine manufacturing facilities

On 28th November, Prime Minister of India, Narendra Modi undertook a three-city tour to the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad, and Serum Institute of India in Pune......................

ICMR backed Serum Institute’s COVISHIELD completes enrolment of Phase III clinical...

Under the strategic alliance, Indian Council for Medical Research is providing continuous support to Serum Institute of India in conducting and funding the ongoing clinical trials of COVISHIELD across 15 centres in India....................